Ambrx Biopharma Inc. (NASDAQ: AMAM) – Not A Clear Buying Opportunity?
Ambrx Biopharma Inc. (AMAM) concluded trading on Thursady at a closing price of $27.93, with 7.75 million shares of worth about $216.32 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 107.81% during that period and on Thursady the price saw a gain of […]
These Numbers Could Change Investor Views For Ambrx Biopharma Inc. (NASDAQ: AMAM)
Cormorant Asset Management LP recently announced the acquisition of new stake in Ambrx Biopharma Inc. (NASDAQ:AMAM). The institutional investor has increased its shareholding in the Healthcare company by 13.17% to 11.23 million shares with purchase of 1.31 million shares. This fresh investment now brings its stake to 17.79% valued currently at $129.61 million. In addition, […]
